Selecting the Best Heart Failure Surgeons and Hospitals in India: A Guide for Patients from Iraq

Author:- Dr. Dheeraj Bojwani Date Created:- 14-08-2026

Over the years, I have found that heart failure is one of the diagnoses Iraqi families most often misunderstand as a single condition with a single treatment path, when it is genuinely a spectrum, from medication and lifestyle management at one end to mechanical circulatory support and heart transplantation at the other. In my experience of 24 years advising patients through exactly this decision, the single most important question is not simply which hospital to choose, but which specific point on that spectrum your particular stage of heart failure actually calls for, since the wrong answer to that question matters far more than which country you travel to.

Healing Journeys of Iraqi Patients

Iraqi Patients Share Their Experience

Why the Choice of Heart Failure Team in India Matters as Much as the Choice of Hospital

Based on my interactions with international patients, the published data on advanced heart failure makes the stakes of this decision very clear. End-stage heart failure left on medical therapy alone carries a genuinely dismal prognosis, with published Indian medical literature citing a five-year survival of only around 25 percent for this stage of disease. Mechanical circulatory support has changed this picture dramatically for appropriately selected patients: a comparative analysis presented in 2025 found that two-year survival with a modern continuous-flow left ventricular assist device, or LVAD, was 88.7 percent, essentially matching the 90.2 percent two-year survival seen with heart transplantation in the same younger patient population after adjusting for baseline differences between groups. A single Indian centre’s own published series of 257 heart transplants performed between 2012 and 2019 documented genuine, sustained domestic experience with this exact procedure, including managing the specific infectious and rejection-related complications that follow transplant surgery. What this tells a family is important: the decision between medical therapy, an LVAD, and transplantation is not a simple hierarchy from worse to better, it is a genuinely individualised choice that depends on your specific stage of disease, age, and candidacy for each option, and a team’s specific experience guiding this choice matters as much as their surgical skill.

How Patients from Iraq Can Verify a Heart Failure Hospital’s Accreditation in India

The fastest filter I recommend to every Iraqi family calling about advanced heart failure is verifiable accreditation, not marketing language. Joint Commission International, JCI, audits a hospital’s overall clinical safety systems against the same standard used across the United States and Europe. The National Accreditation Board for Hospitals and Healthcare Providers, NABH, is India’s own domestic equivalent, and in my experience of 24 years advising families on this exact decision, a centre holding both marks together is a meaningfully stronger signal than either alone. For advanced heart failure specifically, ask one further, very direct question: does this hospital have a dedicated heart failure programme offering the full spectrum of treatment, from device therapy through LVAD implantation to heart transplantation, or does it offer only one or two of these options and refer elsewhere for the rest.

Heart Failure Volume and Treatment-Pathway Criteria That Predict Outcomes in India

Based on my interactions with dozens of heart failure programmes over the years, a centre’s specific experience across the full treatment spectrum, not simply its volume in one procedure, is one of the clearest predictors of a good outcome, since the right treatment pathway for you may only become clear after careful, specialised evaluation. Ask directly, in writing:

1. Does this hospital offer LVAD implantation as both a bridge to transplant and as destination therapy for patients who are not transplant candidates, and how many of each has the team performed?
2. What is the centre's own heart transplant survival at one year and beyond, and how many transplants has this specific team performed in recent years?
3. How is the decision made between LVAD and transplant for a specific patient, and does a multidisciplinary heart failure team make this decision together rather than a single cardiologist or surgeon?
4. What is the centre's specific experience managing right heart failure after LVAD implantation, since this is a recognised complication that significantly affects outcomes and requires specific expertise to manage well?

A centre confident in its own outcomes will answer these specifically. A centre that offers only one treatment option regardless of your specific disease stage deserves a second opinion before you commit.

Vetting a Heart Failure Hospital in India: A Guide for Patients from Iraq

Questions Patients from Iraq Should Ask About the Heart Failure Team in India

Advanced heart failure treatment is never genuinely the work of one specialist alone. In my experience of 24 years watching these programmes operate, the strongest units bring together a heart failure cardiologist to manage medical optimisation and guide the overall pathway, a cardiac surgeon experienced specifically in both LVAD implantation and transplantation, a transplant coordinator to manage the practical logistics of donor matching and post-transplant care, and a dedicated mechanical circulatory support team for the specific, ongoing management an LVAD requires after implantation. A nephrologist is often part of the extended team as well, since advanced heart failure and kidney function are closely linked, and managing both together requires specific coordination that a cardiology team working in isolation may not provide. Ask specifically who fills each of these roles for your case, and confirm that your treatment pathway has been discussed by this full team together, not decided in isolation by whichever specialist you happened to see first.

Heart Failure Technology and Infrastructure Standards in India That Patients from Iraq Should Check

The specific technology and infrastructure available changes what a centre can safely offer across the full heart failure spectrum. Ask whether the hospital offers the latest generation of continuous-flow LVAD technology, since device generation has measurably improved survival and reduced certain complications compared with older device types, including the risk of device thrombosis and hemocompatibility-related complications that earlier generations were more prone to. Ask whether the hospital has a dedicated mechanical circulatory support outpatient clinic for long-term LVAD management, since patients living with these devices need structured, ongoing monitoring for the rest of the device’s operation, including regular device parameter checks and anticoagulation management. For transplant candidates specifically, ask about the centre’s access to a functioning organ donation network and its typical waiting time for a matched donor heart. Ask directly which of these specific capabilities apply to your case, not simply whether the hospital owns the equipment somewhere in the building.

Red Flags Patients from Iraq Should Watch For When Choosing a Heart Failure Hospital in India

Over the years, certain patterns have become reliable warning signs for me. A hospital that recommends the same treatment, whether LVAD or transplant, for every advanced heart failure patient without an individualised evaluation of candidacy for each option has not engaged with the actual complexity of your case. A centre that cannot state its own transplant or LVAD-specific survival data, offering only a general reassurance about heart failure care, has not given you information you can use. And a centre without a dedicated, structured plan for long-term LVAD or post-transplant follow-up is asking you to manage a lifelong condition without the ongoing support it genuinely requires.

Factors Every Patient from Iraq Should Weigh Before Choosing Heart Failure Treatment in India

A Closing Thought for Iraqi Families

Advanced heart failure deserves a treatment pathway chosen by a genuinely multidisciplinary team with deep experience across the full spectrum of options, not a single procedure recommended by a single specialist regardless of your specific stage of disease. Based on my interactions with international patients over more than two decades, the families who ask about treatment-pathway decision-making, device-specific and transplant-specific outcomes, and long-term follow-up infrastructure consistently make better-informed decisions than those who accept a single recommendation without question. My role, and the role of any advisor a family works with, should be to help you ask these exact questions and confirm honestly that the specific team and specific hospital in front of you are the right fit for your family’s exact situation. Iraq’s families deserve the same standard of scrutiny in this decision as any family anywhere else in the world.

Sources & Further Reading

• Joint Commission International (JCI) — Accredited Organizations Directory (jointcommissioninternational.org)
• National Accreditation Board for Hospitals & Healthcare Providers (NABH), India (nabh.co)
• PubMed Central — Management Protocols for Chronic Heart Failure in India (pmc.ncbi.nlm.nih.gov)
• PubMed Central — Medium Term Results Following Heart Transplantation for End Stage Heart Failure: A Single Centre Experience of 257 Patients (pmc.ncbi.nlm.nih.gov)
• Journal of the American College of Cardiology: Heart Failure — LVAD vs. Heart Transplant Survival Comparison (jacc.org)

Frequently Asked Questions by Iraqi Patients about Selecting a Heart Failure Surgeon and Hospital in India